A pilot study of supraphysiologic testosterone (T) and oral etoposide (E) in men with castrate-resistant prostate cancer (CRPC).
Michael Thomas Schweizer
No relevant relationships to disclose
Emmanuel S. Antonarakis
No relevant relationships to disclose
Hao Wang
No relevant relationships to disclose
Avery N. Spitz
No relevant relationships to disclose
Haiyi Cao
No relevant relationships to disclose
Alberto Pacheco
No relevant relationships to disclose
Mario A. Eisenberger
No relevant relationships to disclose
Michael Anthony Carducci
No relevant relationships to disclose
Samuel R. Denmeade
No relevant relationships to disclose